Cargando…
Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
The systemic administration of paclitaxel (PTX)-based combinatorial therapies is significantly restricted due to the multidrug resistance. Curcumin (CUR) not only inhibits cancer-cell proliferation but also reverses the PTX resistance. However, achieving codelivery of these two drugs is a challenge...
Autores principales: | Karaosmanoglu, Sena, Zhang, Yunsen, Zhou, Wenli, Ouyang, Defang, Chen, Xianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774928/ https://www.ncbi.nlm.nih.gov/pubmed/36551021 http://dx.doi.org/10.3390/bioengineering9120815 |
Ejemplares similares
-
Revisiting Curcumin Chemistry Part I: A New Strategy for the Synthesis of Curcuminoids
por: Rao, E. Venkata, et al.
Publicado: (2011) -
Studies on Curcumin and Curcuminoids. XXXIX. Photophysical Properties of Bisdemethoxycurcumin
por: Nardo, Luca, et al.
Publicado: (2010) -
Retro-Curcuminoids as Mimics of Dehydrozingerone and Curcumin: Synthesis, NMR, X-ray, and Cytotoxic Activity
por: Obregón-Mendoza, Marco A., et al.
Publicado: (2016) -
High Yield Synthesis of Curcumin and Symmetric Curcuminoids: A “Click” and “Unclick” Chemistry Approach
por: Obregón-Mendoza, Marco A., et al.
Publicado: (2022) -
Fabrication, Evaluation, and Antioxidant Properties of Carrier-Free Curcumin Nanoparticles
por: Wu, Jinwei, et al.
Publicado: (2023)